Clinical Trials · NCT06256419
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Enrollment
- 300
- Start date
- Jan 2024
- Locations
- 1 site, China
- Primary endpoint
- Change from baseline HbA1c and baseline weight at 6 month